Camila Scharf
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Camila Scharf has a total of 163 co-authors. Here are the top co-authors by number of shared publications:
- Giuseppe Argenziano
Dermatology Unit, Department of Mental and Physical Health and Preventive Medicine University of Campania Luigi Vanvitelli Naples Italy
17 shared publications - Gabriella Brancaccio
Dermatology Unit University of Campania L.Vanvitelli Naples Italy
8 shared publications Giuseppe Argenziano
Dermatology Unit, University of Campania, Naples, Italy
8 shared publications- Eugenia Veronica Di Brizzi
Dermatology Unit, University of Campania L. Vanvitelli, Naples, Italy
7 shared publications - Elvira Moscarella
Dermatology Unit, Department of Mental and Physical Health and Preventive Medicine University of Campania Luigi Vanvitelli Naples Italy
6 shared publications - Giulia Briatico
Dermatology Unit University of Campania L. Vanvitelli Naples Italy
6 shared publications
Latest Publications
- 15 October 2026
- Published by Wiley in International Journal of Dermatology
When Dermoscopy Is Not Enough: RCM and LC ‐ OCT in Basal Cell Carcinoma Diagnosis
- 15 October 2026
- Published by Wiley in International Journal of Dermatology
When Dermoscopy Is Not Enough: RCM and LC ‐ OCT in Basal Cell Carcinoma Diagnosis
- Open Access
- 5 October 2026
- Published by Wiley in JEADV Clinical Practice
When Age and Morphology Mislead: Flat Vulvar Melanoma In Situ in a Young Woman
Pigmented vulvar lesions are frequently encountered in clinical practice and are most often benign, particularly in young women presenting with flat lesions. In contrast, vulvar melanoma predominantly affects postmenopausal patients and is typically associated with raised or palpable morphology, features that usually prompt diagnostic investigation. We report the case of a 28‐year‐old woman presenting with an asymptomatic, flat pigmented lesion of the labia majora that appeared clinically low risk. Dermoscopic examination revealed asymmetric multicomponent pigmentation with blue–white veil and irregular dots and globules, supporting the decision to perform an excisional biopsy in the context of clinic–dermoscopic correlation. Histopathological findings confirmed melanoma in situ. This case illustrates a clinically important variation from the expected presentation of vulvar melanoma and highlights the potential risk of relying solely on reassuring demographic features. Careful clinical assessment and dermoscopic evaluation remain essential in the assessment of vulvar pigmented lesions, even in young patients with flat, apparently benign‐appearing lesions.
- 5 October 2026
- Published by Wiley in JEADV Clinical Practice
Open AccessWhen Age and Morphology Mislead: Flat Vulvar Melanoma In Situ in a Young Woman
Pigmented vulvar lesions are frequently encountered in clinical practice and are most often benign, particularly in young women presenting with flat lesions. In contrast, vulvar melanoma predominantly affects postmenopausal patients and is typically associated with raised or palpable morphology, features that usually prompt diagnostic investigation. We report the case of a 28‐year‐old woman presenting with an asymptomatic, flat pigmented lesion of the labia majora that appeared clinically low risk. Dermoscopic examination revealed asymmetric multicomponent pigmentation with blue–white veil and irregular dots and globules, supporting the decision to perform an excisional biopsy in the context of clinic–dermoscopic correlation. Histopathological findings confirmed melanoma in situ. This case illustrates a clinically important variation from the expected presentation of vulvar melanoma and highlights the potential risk of relying solely on reassuring demographic features. Careful clinical assessment and dermoscopic evaluation remain essential in the assessment of vulvar pigmented lesions, even in young patients with flat, apparently benign‐appearing lesions.
- Open Access
- 29 September 2026
- Published by Wiley in International Journal of Dermatology
- Vol. 65 (S1)
Dermoscopy and the Early Melanoma Concept
Dermoscopy has enabled the detection of increasingly subtle melanocytic lesions and has contributed to a marked rise in early melanoma diagnoses. However, this shift has not been matched by a proportional reduction in mortality, raising the question of whether all lesions currently classified as early melanoma are biologically meaningful. Part of the problem lies in the definition itself. “Early melanoma” is often treated as a uniform entity, yet it likely includes lesions with widely different biological trajectories. Dermoscopy, based on the recognition of morphological patterns, does not access this biological dimension. It captures structure, not behavior and therefore operates within an inherent limitation: atypia does not necessarily equate to clinically relevant malignancy. In practice, lesions may appear suspicious yet remain unchanged over time, while others evolve. This simple observation introduces a critical dimension that static assessment cannot capture. Stability challenges the significance of atypia, while change raises concern—but neither fully resolves the underlying uncertainty. Dermoscopy, therefore, does not diagnose early melanoma in a definitive sense. It identifies lesions that warrant attention within a biologically heterogeneous spectrum. Sequential observation does not eliminate ambiguity, but places it in context, where time becomes part of the evaluation rather than an afterthought. The key issue may not be how early melanoma can be detected, but how to distinguish lesions that will evolve from those that will not. image
- 29 September 2026
- Published by Wiley in International Journal of Dermatology
- Vol. 65 (S1)
Open AccessDermoscopy and the Early Melanoma Concept
Dermoscopy has enabled the detection of increasingly subtle melanocytic lesions and has contributed to a marked rise in early melanoma diagnoses. However, this shift has not been matched by a proportional reduction in mortality, raising the question of whether all lesions currently classified as early melanoma are biologically meaningful. Part of the problem lies in the definition itself. “Early melanoma” is often treated as a uniform entity, yet it likely includes lesions with widely different biological trajectories. Dermoscopy, based on the recognition of morphological patterns, does not access this biological dimension. It captures structure, not behavior and therefore operates within an inherent limitation: atypia does not necessarily equate to clinically relevant malignancy. In practice, lesions may appear suspicious yet remain unchanged over time, while others evolve. This simple observation introduces a critical dimension that static assessment cannot capture. Stability challenges the significance of atypia, while change raises concern—but neither fully resolves the underlying uncertainty. Dermoscopy, therefore, does not diagnose early melanoma in a definitive sense. It identifies lesions that warrant attention within a biologically heterogeneous spectrum. Sequential observation does not eliminate ambiguity, but places it in context, where time becomes part of the evaluation rather than an afterthought. The key issue may not be how early melanoma can be detected, but how to distinguish lesions that will evolve from those that will not. image
- 15 July 2026
- Published by Wiley in International Journal of Dermatology
- Vol. 65 (11) , 2436-2438
Granular Cell Tumor Mimicking Common Skin Neoplasms: Two Cases Highlighting a Shared Dermoscopic Clue
- 15 July 2026
- Published by Wiley in International Journal of Dermatology
- Vol. 65 (11) , 2436-2438
Granular Cell Tumor Mimicking Common Skin Neoplasms: Two Cases Highlighting a Shared Dermoscopic Clue
- 10 June 2026
- Published by Wiley in International Journal of Dermatology
- Vol. 65 (12) , 2623-2625
Line‐Field Confocal Optical Coherence Tomography ( LC ‐ OCT ) Characterization of the Three‐Dimensional ( 3D ) Yellow Dot in Dissecting Cellulitis of the Scalp: A Case Series With Histopathological Correlation
- 10 June 2026
- Published by Wiley in International Journal of Dermatology
- Vol. 65 (12) , 2623-2625
Line‐Field Confocal Optical Coherence Tomography ( LC ‐ OCT ) Characterization of the Three‐Dimensional ( 3D ) Yellow Dot in Dissecting Cellulitis of the Scalp: A Case Series With Histopathological Correlation
- Open Access
- 30 January 2026
- Published by Mattioli1885 in Dermatology Practical & Conceptual
- Vol. 16 (1) , 6995
Blue Lesions in Dermoscopy: A Practical Guide to Risk Stratification and Management
- 30 January 2026
- Published by Mattioli1885 in Dermatology Practical & Conceptual
- Vol. 16 (1) , 6995
Open AccessBlue Lesions in Dermoscopy: A Practical Guide to Risk Stratification and Management
- 9 December 2025
- Published by Wiley in International Journal of Dermatology
- Vol. 65 (5) , 1112-1113
The Gray Zone of Dysplastic Nevi: A National Survey of Italian Dermatologists
- 9 December 2025
- Published by Wiley in International Journal of Dermatology
- Vol. 65 (5) , 1112-1113
The Gray Zone of Dysplastic Nevi: A National Survey of Italian Dermatologists
- 14 November 2025
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 40 (6)
Likelihood of detecting melanoma in lesions clinically and dermoscopically suspected as pyogenic granuloma
- 14 November 2025
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 40 (6)
Likelihood of detecting melanoma in lesions clinically and dermoscopically suspected as pyogenic granuloma
- Open Access
- 8 October 2025
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (19) , 9799
Ocular Melanoma: A Comprehensive Review with a Focus on Molecular Biology
Ocular melanoma is a rare but clinically significant malignancy, primarily comprising uveal and conjunctival subtypes. Although sharing some histopathological features with cutaneous melanoma, these tumours are characterized by distinct molecular and biological profiles with direct implications for prognosis and treatment. Uveal melanoma is predominantly driven by mutations in GNAQ and GNA11, along with alterations in BAP1, SF3B1, and EIF1AX, which are key prognostic determinants. Conversely, conjunctival and eyelid melanoma exhibits greater molecular similarity to cutaneous melanoma, commonly involving BRAF, NRAS, NF1, and TERT promoter mutations. Despite progress in the molecular characterization of these entities, metastatic disease continues to confer a poor prognosis, particularly in uveal melanoma. Ongoing research into the molecular basis of ocular melanoma is essential to advance targeted therapies and improve clinical outcomes. The aim of this review is to provide a comprehensive overview of ocular melanoma, with a particular focus on the molecular biology underlying its clinical behaviour and emerging therapeutic opportunities.
- 8 October 2025
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (19) , 9799
Open AccessOcular Melanoma: A Comprehensive Review with a Focus on Molecular Biology
Ocular melanoma is a rare but clinically significant malignancy, primarily comprising uveal and conjunctival subtypes. Although sharing some histopathological features with cutaneous melanoma, these tumours are characterized by distinct molecular and biological profiles with direct implications for prognosis and treatment. Uveal melanoma is predominantly driven by mutations in GNAQ and GNA11, along with alterations in BAP1, SF3B1, and EIF1AX, which are key prognostic determinants. Conversely, conjunctival and eyelid melanoma exhibits greater molecular similarity to cutaneous melanoma, commonly involving BRAF, NRAS, NF1, and TERT promoter mutations. Despite progress in the molecular characterization of these entities, metastatic disease continues to confer a poor prognosis, particularly in uveal melanoma. Ongoing research into the molecular basis of ocular melanoma is essential to advance targeted therapies and improve clinical outcomes. The aim of this review is to provide a comprehensive overview of ocular melanoma, with a particular focus on the molecular biology underlying its clinical behaviour and emerging therapeutic opportunities.
- Open Access
- 22 September 2025
- Published by Elsevier in Biocybernetics and Biomedical Engineering
- Vol. 45 (4) , 608-616
Design and development of a systematic validation protocol for synthetic melanoma images for responsible use in medical artificial intelligence
- 22 September 2025
- Published by Elsevier in Biocybernetics and Biomedical Engineering
- Vol. 45 (4) , 608-616
Open AccessDesign and development of a systematic validation protocol for synthetic melanoma images for responsible use in medical artificial intelligence